Toronto Dominion Bank Compass Therapeutics, Inc. Transaction History
Toronto Dominion Bank
- $49.5 Billion
- Q1 2025
A detailed history of Toronto Dominion Bank transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Toronto Dominion Bank holds 75,000 shares of CMPX stock, worth $195,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75,000Holding current value
$195,000% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CMPX
# of Institutions
127Shares Held
101MCall Options Held
2.52MPut Options Held
3.1M-
Orbimed Advisors LLC San Diego, CA22.4MShares$58.1 Million1.32% of portfolio
-
Tang Capital Management LLC San Diego, CA11.1MShares$28.7 Million1.36% of portfolio
-
Blackstone Inc New York, NY10MShares$26.1 Million0.09% of portfolio
-
Bio Impact Capital LLC Cambridge, MA8.44MShares$22 Million2.97% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$17.2 Million0.0% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $263M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...